title: Obstructive lung diseases and beta-blockers: Where do we stand?
authors.affiliation: Allergy Center, CUF Descobertas Hospital and CUF Infante Santo Hospital, Lisbon, Portugal; CEDOC, Chronic Diseases Research Center, NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal. Electronic address: helenampite@gmail.com.
authors.forename: Helena
authors.initials: H
authors.lastname: Pité
authors.affiliation: Allergy Center, CUF Descobertas Hospital and CUF Infante Santo Hospital, Lisbon, Portugal.
authors.forename: Marisa Braga
authors.initials: MB
authors.lastname: da Cruz
authors.affiliation: Allergy Center, CUF Descobertas Hospital and CUF Infante Santo Hospital, Lisbon, Portugal; CINTESIS, Center for Research in Health Technologies and Information Systems, Porto, Portugal.
authors.forename: Mário
authors.initials: M
authors.lastname: Morais-Almeida
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy; D001281:Atrial Fibrillation / Q000188:drug therapy; D003324:Coronary Artery Disease / Q000188:drug therapy; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic
chemical_list: D000319:Adrenergic beta-Antagonists
keywords: Asthma; Atrial fibrillation; Beta-blocker; Chronic obstructive pulmonary disease; Coronary artery disease; Heart failure